A genetic profiling guideline to support diagnosis and clinical management of lymphomas
Margarita Sanchez Beato Gomez, Miriam Méndez García, María Guirado, Lucía Pedrosa, Silvia Sequero, N. Yanguas Casás, Luis de la Cruz-Merino, Laura Gálvez Carvajal, Marta Llanos Muñoz, Juan Fernando García García, Mariano Provencio Pulla
págs. 1043-1062
Immunoradiotherapy for NSCLC: mechanisms, clinical outcomes, and future directions
He Weishan, Zheng Donglin, Deng Guangmei, Liu Wenya, Wu Fasheng, Chen Jibing
págs. 1063-1076
Benjamin Robles Bañuelos, Adriana Romo Perez, Guadalupe Dominguez Gomez, Alma Chavez Blanco, Aurora Gonzalez Fierro, Alfonso Dueñas González
págs. 1077-1088
Indicators to evaluate quality of care in head and neck cancer in Spain
Juan Jesús Cruz Hernández, Virginia Arrazubi Arrula, Yolanda Escobar Álvarez, Almudena García Castaño, Juan J. Grau de Castro, Lara Iglesias Docampo, Julio José Lambea Sorrosal, Pedro Pérez Segura, Antonio Rueda Domínguez, F.J. Campos Lucas, Irene Santamaría Rodríguez, Maria Bessa, Paula Gratal, F. Caballero Martínez, Diana Monge Martín, Cristina Antón Rodríguez, Rafael López López
págs. 1089-1097
Endometrial cancer: predictors and oncological safety of tumor tissue manipulation
Raquel Quintana Bertó, Pablo Padilla Iserte, Victor Lago Leal, Carmen Manuela Tauste Rubio, Berta Díaz Feijoo, Silvia Cabrera Díaz, Mª de los Reyes Oliver Pérez, Pluvio J. Coronado Martín, B. Martín Salamanca, Manuel Pantoja Garrido, Josefa Marcos Sanmartín, Eduardo Cazorla Amorós, Cristina Lorenzo, José Ramón Rodríguez Hernández, Fernando Roldan Rivas, Juan Gilabert Estellés, Juan Carlos Muruzábal Torquemada, Antonio José Cañada Martínez, S. Domingo del Pozo
págs. 1098-1105
Predictive value of NLR and PLR for immune-related adverse events: a systematic review and meta-analysis
Hong-Rui Lu, Peng-Fei Zhu, Ya-Ya Deng, Zhe-Ling Chen, Liu Yang
págs. 1106-1116
Vayda Schüttke, Cathrin Kusiek, Susanne Fuessel, Christian Thomas, Bjoern Thorben Buerk, Kati Erdmann
págs. 1117-1128
Current status of fertility preservation in a Spanish tertiary public hospital: multidisciplinary approach and experience in over 1500 patients
Yasmina Barral El Gaoui, Aina Borrás Capó, Pilar Carrillo, Inés Agustí Sunyer, Sara Peralta, Gemma Casals Soler, Francisco Fábregues, Marta Guimera, Juan Manuel Corral Molina, Josep M. Calafell Pozo, Miriam Redondo, Ariel Glickman, Montserrat Rovira, B. Adamo, Elena Ricart, Dolors Manau Trullàs
págs. 1129-1138
págs. 1139-1146
Sexual dysfunction in patients with cancer, a challenge in oncology practice: results of the CLARIFY project
Aylen Vanessa Ospina Serrano, C. Maximiano Alonso, Blanca Cantos Sánchez de Ibargüen, María Torrente Regidor, Miriam Méndez García, Juan Cristóbal Sánchez, V. Calvo de Juan, Ana Collazo Lorduy, Mariola Blanco Clemente, Beatriz Núñez García, I. Triana, Consuelo Parejo, Paula Martinez, Narjust Duma, Mariano Provencio Pulla
págs. 1147-1156
págs. 1157-1169
págs. 1170-1186
A gastric sarcoma from 3000 years ago: paleopathological diagnosis at the field
págs. 1187-1191
Shida Yan, Lili Liu, Xing Zhang, Lijun Wei, Wenmei Jiang, Xianlu Gao, Ankui Yang, Xuekui Liu, Wenkuan Chen, Yanfeng Chen, Hui Li, Qiaohong Lin, Menghua Li, Jingtao Chen, Quan Zhang, Shuwei Chen, Ming Song
págs. 1192-1202
Biologically effective dose (BED) value lower than 120 Gy improve outcomes in lung SBRT
Esther Jimenez Jimenez, M. M. Martí Laosa, J. M. Nieto-Guerrero Gómez, Maria Esperanza Perez, Marian Gómez, Eva Mª Lozano Martín, Sebastià Sabater
págs. 1203-1208
págs. 1209-1219
Laia Bernet Vegué, Carolina Cantero González, Magdalena Sancho de Salas, David Parada, Tiziana Perin, Zulma Quintero Niño, Begoña Vieites Pérez-Quintela, Douglas Sánchez, Marina Castelvetere, David Hardisson Hernáez, María Dolores Martín Salvago
págs. 1220-1228
Dariusz Kajdaniuk, Dorota Hudy, Joanna Katarzyna Strzelczyk, Krystyna Młynarek, Szymon Słomian, Andrzej Potyka, Ewa Szymonik, Janusz Strzelczyk, Wanda Foltyn, Beata Kos-Kudła, Bogdan Marek
págs. 1229-1239
Cong Lai, Zhikai Wu, Zhuohang Li, Xin Huang, Zhensheng Hu, Hao Yu, Zhihan Yuan, Juanyi Shi, Jintao Hu, Yelisudan Mulati, Cheng Liu, Kewei Xu
págs. 1240-1255
Katerina Katsaraki, Christos K. Kontos, Gerasimos Ardavanis-Loukeris, Alexandros A. Tzovaras, Diamantis C. Sideris, Andreas Scorilas
págs. 1259-1267
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
Lena Weiss, V. Heinemann, Laura E. Fischer, Frank Gieseler, Thomas Hoehler, Julia Mayerle, Detlef Quietzsch, Anke Reinacher-Schick, Michael Schenk, Gernot Seipelt, J. T. Siveke, Michael Stahl, Ursula Vehling-Kaiser, Dirk T. Waldschmidt, Klara Dorman, Danmei Zhang, C. B. Westphalen, Michael S. von Bergwelt Baildon, S. Boeck, M. Haas
págs. 1268-1272
Distribution of PD-L1, TROP2 and HER2- “lowness” in early triple-negative breast cancer: an opportunity for treatment de-escalation
Maria Jose Bueno Verdejo, Silvana Mouron, Eduardo Caleiras, Mario Martínez López, Luis Manso Sánchez, Ramón Colomer Bosch, Miguel Quintela-Fandino
págs. 1273-1279
© 2001-2024 Fundación Dialnet · Todos los derechos reservados